CGRPs Promising for Prevention of Chronic Cluster Headache

Treatment with CGRP monoclonal antibodies may reduce the frequency of chronic cluster headache attacks in patients with an inadequate response to other preventive medications, new research shows.
Medscape Medical News

Source link

Related posts

clinical neurology; +103 new citations


Spotlight on the October 29 issue


What’s the Secret to Lasting Health and Happiness?


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World